ATE449344T1 - Quantifizierung des carnitinspiegels bei dialyse- patienten - Google Patents
Quantifizierung des carnitinspiegels bei dialyse- patientenInfo
- Publication number
- ATE449344T1 ATE449344T1 AT03770386T AT03770386T ATE449344T1 AT E449344 T1 ATE449344 T1 AT E449344T1 AT 03770386 T AT03770386 T AT 03770386T AT 03770386 T AT03770386 T AT 03770386T AT E449344 T1 ATE449344 T1 AT E449344T1
- Authority
- AT
- Austria
- Prior art keywords
- carnitine
- deficiency
- methods
- diagnosing
- quantifying
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title abstract 4
- 229960004203 carnitine Drugs 0.000 title abstract 4
- 238000000502 dialysis Methods 0.000 title abstract 2
- 238000011002 quantification Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 5
- 206010058892 Carnitine deficiency Diseases 0.000 abstract 4
- 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 abstract 4
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 238000004885 tandem mass spectrometry Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/173845—Amine and quaternary ammonium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/252,115 US7011977B2 (en) | 1999-01-30 | 2002-09-23 | Quantification of carnitine levels in dialysis patients |
| PCT/US2003/029821 WO2004026114A2 (en) | 2002-09-23 | 2003-09-23 | Quantification of carnitine levels in dialysis patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449344T1 true ATE449344T1 (de) | 2009-12-15 |
Family
ID=32029013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03770386T ATE449344T1 (de) | 2002-09-23 | 2003-09-23 | Quantifizierung des carnitinspiegels bei dialyse- patienten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7011977B2 (de) |
| EP (1) | EP1587406B1 (de) |
| AT (1) | ATE449344T1 (de) |
| AU (1) | AU2003278872A1 (de) |
| CY (1) | CY1110607T1 (de) |
| DE (1) | DE60330185D1 (de) |
| DK (1) | DK1587406T3 (de) |
| ES (1) | ES2336787T3 (de) |
| PT (1) | PT1587406E (de) |
| SI (1) | SI1587406T1 (de) |
| WO (1) | WO2004026114A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7297545B2 (en) * | 1999-01-30 | 2007-11-20 | Pediatrix Screening, Inc. | Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor |
| US7333894B2 (en) * | 2002-01-31 | 2008-02-19 | Sigma-Tau Pharmaceuticals, Inc. | Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients |
| WO2006098192A1 (ja) * | 2005-03-16 | 2006-09-21 | Ajinomoto Co., Inc. | 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体 |
| WO2016013115A1 (ja) * | 2014-07-25 | 2016-01-28 | 株式会社 リージャー | 希釈生体試料成分の分析方法 |
| GB201916046D0 (en) * | 2019-11-04 | 2019-12-18 | Amazentis Sa | Diagnostic method |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252489A (en) * | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
| US5316917A (en) * | 1992-11-04 | 1994-05-31 | Duke University | Automated analysis of free l-carnitine and total short-chain acylcarnitine |
| US6258605B1 (en) * | 1999-03-26 | 2001-07-10 | Neo Gen Screening, Inc. | Clinical method for the genetic screening of newborns using tandem mass spectrometry |
| US6455321B1 (en) * | 1999-01-30 | 2002-09-24 | Neo Gen Screening, Inc. | Method for interpreting tandem mass spectrometry data for clinical diagnosis |
| IT1306178B1 (it) * | 1999-07-27 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da |
| IT1306179B1 (it) * | 1999-07-28 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale. |
| US6429230B1 (en) * | 2000-01-19 | 2002-08-06 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Treating chronic uremic patients undergoing periodical dialysis |
| US6335369B1 (en) * | 2000-01-19 | 2002-01-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Treating chronic uremic patients undergoing periodical dialysis |
-
2002
- 2002-09-23 US US10/252,115 patent/US7011977B2/en not_active Expired - Lifetime
-
2003
- 2003-09-23 ES ES03770386T patent/ES2336787T3/es not_active Expired - Lifetime
- 2003-09-23 DE DE60330185T patent/DE60330185D1/de not_active Expired - Lifetime
- 2003-09-23 AU AU2003278872A patent/AU2003278872A1/en not_active Abandoned
- 2003-09-23 WO PCT/US2003/029821 patent/WO2004026114A2/en not_active Ceased
- 2003-09-23 AT AT03770386T patent/ATE449344T1/de active
- 2003-09-23 EP EP03770386A patent/EP1587406B1/de not_active Expired - Lifetime
- 2003-09-23 DK DK03770386.5T patent/DK1587406T3/da active
- 2003-09-23 PT PT03770386T patent/PT1587406E/pt unknown
- 2003-09-23 SI SI200331740T patent/SI1587406T1/sl unknown
-
2010
- 2010-02-11 CY CY20101100137T patent/CY1110607T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1587406A2 (de) | 2005-10-26 |
| PT1587406E (pt) | 2010-02-23 |
| AU2003278872A1 (en) | 2004-04-08 |
| DE60330185D1 (de) | 2009-12-31 |
| WO2004026114A3 (en) | 2004-08-19 |
| SI1587406T1 (sl) | 2010-03-31 |
| ES2336787T3 (es) | 2010-04-16 |
| CY1110607T1 (el) | 2015-04-29 |
| EP1587406A4 (de) | 2007-01-03 |
| DK1587406T3 (da) | 2010-03-15 |
| AU2003278872A8 (en) | 2004-04-08 |
| US20030129762A1 (en) | 2003-07-10 |
| EP1587406B1 (de) | 2009-11-18 |
| US7011977B2 (en) | 2006-03-14 |
| WO2004026114A2 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2319941A3 (de) | Methode und vorrichtung zur korrelation von biomarker produktmengen mit krankheiten | |
| NO20053976L (no) | Online kilderekonstruksjon for EEG/MEG og ECG/MCG. | |
| BR112017021305A2 (pt) | dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva | |
| WO2008014132A3 (en) | Combination analyte measurement device and method of use | |
| ATE423217T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| EP2306192A3 (de) | Risikomarker für eine Herzkreislaufkrankheit | |
| TW200736606A (en) | Gated voltammetry | |
| EP1978361A3 (de) | Verfahren zur Korrektur eines Blutglucose-Assay-Bias mittels der durch ein Glucose-Hämoglobin-A1C-Kombinationssystem bestimmten Hämoglobinkonzentration und Vorrichtungen dafür | |
| CY1110607T1 (el) | Ποσοτικοποιηση επιπεδων καρνιτινης σε ασθενεις που υποβαλλονται σε αιμοκαθαρση | |
| ATE442592T1 (de) | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten | |
| WO2007126444A3 (en) | Analyte monitoring | |
| UA103474C2 (ru) | Устройство для мониторинга места доступа к сосудистой системе и оборудование для экстракорпорального лечения крови с устройством для мониторинга места доступа к сосудистой системе | |
| WO2008114377A1 (ja) | 運動状態検出装置、運動状態検出プログラム、運動状態検出方法 | |
| WO2008097773A8 (en) | Methods and devices for diagnosis of appendicitis | |
| WO2017070114A3 (en) | Diabetes-related biomarkers and treatment of diabetes-related conditions | |
| WO2006006871A3 (en) | Method and system for monitoring ventilations | |
| EP1310797A3 (de) | Verfahren zur Kontrolle einer nervenschützenden Behandlung | |
| ES2349107T8 (es) | Método analítico e instrumento. | |
| NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| CY1112423T1 (el) | Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| WO2006124526A3 (en) | Method for assessing the effectiveness of a treatment regimen by determining zonulin | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| WO2008145701A9 (en) | Method for predicting the outcome of a critically ill patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1587406 Country of ref document: EP |